NCT03817541

Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients

Expiratory and Plasma Propofol Concentration in Bariatric and Cholecystectomy Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Determination of accuracy With Edmond (reg) expiratory propofol measurement Device, compared With concommitant plasma samples of propofol

Detailed description

Edmon (trade mark) is a New Device from BBraun, measuring the expiratory concentration of propofol in anaesthetized patients. The investigators will test the accuracy and stability of such measurements in comparison With plasma propofol Levels. The investigators will test during target Control infusion (Marsh model) and assumed stable plasma Levels. Plasma samples of propofol will be taken for comparison With exhaled propofol.

Conditions

• Bariatric Surgery Candidate
• Cholecystectomy

Interventions

Type	Name	Description
DEVICE	Edmon (reg), BBraun	exhaled propofol will be compared With plasma propofol values

Timeline

• Start date: 2018-11-14
• Primary completion: 2019-06-30
• Completion: 2020-12-31
• First posted: 2019-01-25
• Last updated: 2019-02-05

Locations

1 site across 1 country: Norway